Speck
Adrien Speck, Marseille FR
Patent application number | Description | Published |
---|---|---|
20120291157 | GPAV GENE RESISTANT TO NEMATODES IN THE SOLANACEA - The invention relates to a GpaV gene providing resistance to nematodes in plants belonging to the nightshade family, and in particular potatoes ( | 11-15-2012 |
Denis Speck, Sainte Foy Les Lyon FR
Patent application number | Description | Published |
---|---|---|
20110207173 | Self-Replicating Vector Lacking An Antibiotic-Resistance Gene - The subject matter of the present invention is a novel vector and the use thereof for producing a heterologous protein or a gene of interest, that can be used, for example, in the context of an immunization or gene therapy programme and concerns in particular a self-replicating vector lacking an antibiotic-resistance gene, comprising a sequence encoding the ccdA protein functionally linked to a first promoter, the sequence of the Cer locus and a heterologous sequence, functionally linked to a second promoter. | 08-25-2011 |
Denis Speck, Lyon FR
Patent application number | Description | Published |
---|---|---|
20090017074 | CULTURE MEDIUM FOR HAEMOPHILUS INFLUENZAE TYPE B - The invention relates to a culture medium for | 01-15-2009 |
James H. Speck, Campbellville CA
Patent application number | Description | Published |
---|---|---|
20110095045 | BODY FILLER DISPENSER - A combination of a body filler and a container for dispensing the body filler, including a filler having a density adapted for containment in the container. The filler includes at least a thermoplastic microsphere and a polyester resin. A container stores and dispenses the filler. The container includes a closable opening, a cylindrical wall, a closure for selective closing the opening, and a plug axially movable within the cylindrical wall of the container. The container plug pushes against a volume of the filler to urge the filler through and opening of the container. | 04-28-2011 |
Juan Antonio Speck, Ontario CA
Patent application number | Description | Published |
---|---|---|
20100050547 | HYBRID WINDOW WALL/CURTAIN WALL SYSTEM AND METHOD OF INSTALLATION - There are currently two major types of exterior building envelope finishing systems: window wall systems, and curtain wall systems. Window wall systems use panels which fit between concrete floor slaps, and hence, are prone to leakage and are not aesthetically appealing. Curtain wall systems are installed proud of the concrete slabs, so have better performance, but are expensive to install. The system of the invention has the high performance of a curtain wall system, with the ease of installation of a window wall system. The invention uses rigid panels which cover the face of a building like a curtain wall system, providing a complete gasketed seal without the need for caulking as in the case of window wall systems. The vertical mullions are notched, so that the mullions can be easily anchored to the upper and lower surfaces of the concrete slabs. | 03-04-2010 |
Neil Speck, New South Wales AU
Patent application number | Description | Published |
---|---|---|
20090222208 | Magnetic Beacon Guidance System - A method of guiding a probe ( | 09-03-2009 |
Thomas Speck, Thalwil CH
Patent application number | Description | Published |
---|---|---|
20120256632 | NMR measuring configuration with optimized sample container geometry and method for calculating the shape of the sample container - A sample container ( | 10-11-2012 |
20130229182 | Gradient coil with correction windings and method for production thereof - In a coil arrangement for nuclear magnetic resonance comprising a main coil ( | 09-05-2013 |
Ulrich Speck, Frauenfeld CH
Patent application number | Description | Published |
---|---|---|
20110295200 | DRUG-ELUTING MEDICAL DEVICE - The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of the vessel subjected to angioplasty. More particularly, the present invention relates to a catheter balloon completely or partially coated with paclitaxel in hydrated crystalline form or in hydrated solvated crystalline form, having an immediate release and bioavailability of a therapeutically effective amount of paclitaxel at the site of intervention. The balloon can be made of a polyether-polyamide block copolymer, or a polyester amide, or polyamide-12. | 12-01-2011 |